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Dear Sir,
We would like to thank Prof. Bergamaschi and his col-
leagues for their commentary [1] on our systematic review 
and meta-analysis “There is no difference in outcome 
between laparoscopic and open surgery for rectal cancer: a 
systematic review and meta-analysis on short- and long-term 
oncologic outcomes” [2]. First of all, we appreciate Prof. 
Bergamaschi’s commentary since his reputation in the colo-
rectal surgery community is indisputable. However, there 
are some points raised in his letter that must be addressed 
and explained because we believe that they are not entirely 
correct.
We agree that there are no data from 1966 to 2005 
included in our meta-analysis. The reason is simple: there 
were no studies published in that time frame that matched 
our inclusion criteria. As described in methodology section 
of the paper, we screened databases covering a period from 
January 1966 to October 2016. Similarly, a recent meta-anal-
ysis by Martinez-Perez et al. [3] searched for papers from 
1995, yet included studies published from 2003 onward. A 
2003 study by Araujo et al. [4] was not included because it 
did not report circumferential resection margin status, an 
inclusion criterion for our review.
We would like to point readers (and Prof Bergamaschi) 
to Table 1 of our paper, where data on mean tumor distance 
from the anal verge are, in fact, reported.
We did not provide data on completeness of mesorectal 
excision in 6 out of 11 studies, since that information was 
not provided by authors of included studies themselves. We 
performed a pooled analysis on data from five studies (all 
studies that reported this outcome) which did not reveal sig-
nificant differences.
Our grouping of “nearly complete” with “complete” 
mesorectal excision cases, based on Nagtegaal’s classifica-
tion, was different from the meta-analysis by Martinez-Perez 
et al. In Nagtegaal’s original publication [5], the authors 
stated: “In our analysis we combined ‘optimal surgery’ cases 
and cases with nearly complete mesorectum, because we 
did not find statistical differences between these groups.” 
In Martinez-Perez’s meta-analysis, “nearly complete” and 
“incomplete” were incorrectly grouped together, as pointed 
out in the invited commentary to his review [6]. We decided 
to follow Nagtegaal’s original publication to reduce bias, and 
it turned out that this indeed changed the results!
We also agree that we did not analyze the design of 
included studies or study sample calculations (which were 
not provided in all studies), and this might have some influ-
ence on the final meta-analysis. However, we believe this 
is of minor importance, especially since the risk of bias in 
included studies was considered low. In our understanding, 
our meta-analysis of well-conducted randomized controlled 
trials (RCTs) provides a high level of evidence on the simi-
larity of total mesorectal excision.
Both laparoscopic and open approaches to rectal cancer 
have their drawbacks. There is one certainty: open surgery 
has many limitations that cannot be overcome, whereas min-
imally invasive access, thanks to its ongoing technological 
advancement, is still evolving. Further comparison through 
RCTs of open and laparoscopic surgery is not needed in our 
opinion, and this is also evidenced by reluctance of patients 
to enroll in ongoing trials comparing open with laparoscopic 
surgery [7, 8]. Instead, we should wait for the results of stud-
ies comparing different laparoscopic/minimally invasive 
techniques to decide the future direction of rectal cancer 
surgery. This may not be using the robot to augment minimal 
access pelvic dissection [9], but maybe using a transanal 
TME when the COLOR III trial has reported [10]. Laparo-
scopic surgery has the same long-term oncological outcomes 
as open surgery in rectal cancer (leaving aside the other 
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advantages of laparoscopic surgery). The debate should now 
focus around which is the best laparoscopic technique to use.
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